ArticleBioengineering (Basel, Switzerland)2023
RGSB-UNet: Hybrid Deep Learning Framework for Tumour Segmentation in Digital Pathology Images.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A multimodal prediction model for brain hematoma expansion based on deep neural network with transformer-driven collaborative attention fusion.Medical & biological engineering & computing · 2026Article
- IFC-HFlowVAE: A self-enhancing generative framework with structural anchoring for imbalanced clinical data augmentation.PloS one · 2026Article
- A multi-task and explainable swin transformer framework for cross-scale computational pathology in gastrointestinal cancer.Frontiers in oncology · 2026Article
- Segmentation of Non-Small Cell Lung Carcinomas: Introducing DRU-Net and Multi-Lens Distortion.Journal of imaging · 2025Article
- Deep Learning Analysis for Predicting Tumor Spread through Air Space in Early-Stage Lung Adenocarcinoma Pathology Images.Cancers · 2024Article
- WWFedCBMIR: World-Wide Federated Content-Based Medical Image Retrieval.Bioengineering (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Colorectal cancer (CRC) is a prevalent gastrointestinal tumour with high incidence and mortality rates. Early screening for CRC can improve cure rates and reduce mortality. Recently, deep convolution neural network (CNN)-based pathological image diagnosis has been intensively studied to meet the challenge of time-consuming and labour-intense manual analysis of high-resolution whole slide images (WSIs). Despite the achievements made, deep CNN-based methods still suffer from some limitations, and the fundamental problem is that they cannot capture global features. To address this issue, we propose a hybrid deep learning framework (RGSB-UNet) for automatic tumour segmentation in WSIs. The framework adopts a UNet architecture that consists of the newly-designed residual ghost block with switchable normalization (RGS) and the bottleneck transformer (BoT) for downsampling to extract refined features, and the transposed convolution and 1 × 1 convolution with ReLU for upsampling to restore the feature map resolution to that of the original image. The proposed framework combines the advantages of the spatial-local correlation of CNNs and the long-distance feature dependencies of BoT, ensuring its capacity of extracting more refined features and robustness to varying batch sizes. Additionally, we consider a class-wise dice loss (CDL) function to train the segmentation network. The proposed network achieves state-of-the-art segmentation performance under small batch sizes. Experimental results on DigestPath2019 and GlaS datasets demonstrate that our proposed model produces superior evaluation scores and state-of-the-art segmentation results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.